Hunan Jiudian Pharmaceutical Co., Ltd. (HUNAN JIUDIAN PHARMACEUTICAL CO) Aktie
300705.SZ
GeschlossenHUNAN JIUDIAN PHARMACEUTICAL CO
Market Cap
$5,648,286,720
Über Hunan Jiudian Pharmaceutical Co., Ltd. (HUNAN JIUDIAN PHARMACEUTICAL CO) Aktie
Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its products portfolio includes Pantoprazole Sodium Enteric-coated, Ferrous Succinate, Rosuvastatin Calcium, Ebastine, and Rabeprazole Sodium Enteric-coated Tablets; and Acetylcysteine Granules, Potassium Sodium Hydrogen Citrate Granules, Loxoprofen Sodium Gel Patch, and Ketoprofen gel patch. The company also offers drugs for analgesic, cardio-cerebrovascular, anti-infection, digestive and urinary system, and breathing and anti-allergy. In addition, it provides CMO/CDMO services. The company was founded in 2001 and is based in Changsha, China.
Unternehmensinformationen
410205 Changsha, China
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.